MyFinsight
Home
About
Contact
xlo: the income statement
Download
Download image
Net loss and
comprehensive loss
-$16,287K
(-16.17%↓ Y/Y)
Total other income
(expense), net
-$14,358K
(-2035.04%↓ Y/Y)
Loss from operations
-$1,929K
(86.93%↑ Y/Y)
Other income
(expense), net
$1,022K
(37.74%↑ Y/Y)
Total revenue
$19,066K
(742.51%↑ Y/Y)
Change in fair value of
common stock warrant...
$15,380K
Total operating
expenses
$20,995K
(23.32%↑ Y/Y)
General and
administrative
$6,674K
(5.82%↑ Y/Y)
Research and development
$14,321K
(33.11%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Xilio Therapeutics, Inc. (XLO)
Xilio Therapeutics, Inc. (XLO)